breast cancer
Conditions
Interventions
Experimental group:Percutaneous point electrical stimulation (TEAS)
Sponsors
Xuzhou Central Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Female patients undergoing unilateral modified radical mastectomy under general anesthesia during March-June 2022; 2. Aged between 18 and 65 years; 3. BMI 19-28 kg/m^2; 4. ASA grade ?-?; 5. All patients were informed of the treatment and experimental plan and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Contraindications for TEAS (scars or skin lesions at the site of irritation, electronic devices such as pacemakers or other implanted medical electronic devices); 2. Difficulty in communication; 3. Previous history of breast surgery; Preoperative acute and chronic pain; 4. Cardiopulmonary insufficiency or severe hypertension; 5. Confirm liver/kidney insufficiency; 6. Substance abuse or addiction; 7. Alcoholism or addiction; 8. Refused to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of chronic pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Pain Numerical Scoring (NRS);Inflammatory factor levels;Postoperative nausea and vomiting;Incidence of chronic pain in 6 months postoperatively;Rescue the use of painkillers and antiemetics;Intraoperative propofol, sufentanil, and remifentanil dosage; | — |
Countries
China
Contacts
Public ContactWang Liwei
Xuzhou Central Hospital
Outcome results
None listed